TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | -2 | 49 | 31 | 37 | 109 | 38 | 
| P | %wins | 100 | 0 | 100 | 100 | 100 | 100 | 83 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/9/23 20:33  | 11/7/23  | LXEO | Lexeo Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Lundbeckfond Invest A/s | G7 | T | P.d | 2,500 | 11.00 | 0 | 227 | 14 | 1,836 | D | ||||||||||||||||
11/12/21 16:15  | 11/9/21  | IOBT | Io Biotech, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lundbeckfond Invest A/S | G7 | T | P.d | 30,000 | 14.00 | 0 | 2,143 | 55 | 6,049 | D | |||||||||||||||
3/16/20 17:07  | 3/16/20  | IMRA | Imara Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lundbeckfond Invest A/s | G7 | T | P.d | 3,000 | 16.00 | 0 | 188 | 15 | 1,433 | D | |||||||||||||||
5/13/19 17:00  | 5/9/19  | TRVI | Trevi Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lundbeckfond Invest A/s | CT | T | P.d | 3,750 | 10.00 | 0 | 375 | 48 | 1,152 | D | |||||||||||||||
11/21/17 19:24  | 11/21/17  | SCPH | Scpharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lundbeckfond Invest A/s | MA | T | P.d | 9,167 | 14.00 | 0 | 655 | 26 | 3,184 | D | |||||||||||||||
2/6/14 15:47  | 2/4/14  | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Lundbeckfond Invest A/s | G7 | T | P.d | 1,461 | 8.00 | 4 | 183 | 12 | 1,746 | D | -9 | 2 | -2 | 49 | 31 | 37 | 109 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |